Dedicated to Serving You

Firm Overview

Gregg Goldfarb of Gregg M. Goldfarb, LLP has over 25 years of experience representing clients, including individuals, small businesses, and medical professionals. His practice provides dedicated representation for clients in cases that include accidents, defective products, insurance claims, PIP insurance claims, civil rights, and whistleblower claims. Representation is focused on suiting your needs and using his knowledge and experience to help you pursue compensation for your injuries. Consultations are always free, and you pay nothing unless there is a settlement or victory that leads to a payout for your claim.

COVID-19 (Coronavirus) update

Dear Clients,
We are all now grappling with an issue of enormous scale and human impact, and our hearts go out to all who have been affected by the outbreak of coronavirus (COVID-19)..

At Gregg M. Goldfarb, we believe it is our responsibility during this time to prioritize the health and well-being of our clients and your legal team while also supporting local health officials and government leaders as they work to contain the virus.

With the input and guidance from the Health Department and the Centers for Disease Control and Prevention (CDC) relating to the coronavirus (COVID-19), we are implementing certain safety measures.

We are equipped and available to do telephone and video conferences. Please let us know if you would prefer this method of communication and we will be happy to accommodate. Should our physical offices need to close for any reason, you will see no disruption in your legal services. Contact Gregg Goldfarb at to set up a meeting or phone call.

As the situation continues to develop, there may be impacts to the judicial system. If you have an upcoming hearing with your attorney and have an elevated risk of transmitting the novel coronavirus, please advise your attorney as soon as possible. The courts will generally allow us to hold hearings telephonically if necessary and this will reduce exposure, as well as allow us to continue advancing your legal needs.

For those of you who have lost their jobs and don’t know how to file for unemployment compensation, please check my website for some basic information to help.

Thank you for continuing to trust your legal team. It is our intent to remain transparent and keep you updated.

We are privileged to represent you.

Warm Regards,

Gregg Goldfarb

Current Defective Products & Mass Tort Cases

3M Earplugs

From 2003-2015, all branches of the US military issued 3M Combat earplugs to soldiers. A design defect in the earplugs made them ineffective, and thousands of soldiers were not afforded the hearing protection they required. The earplugs were not shaped correctly and became unsealed when placed in the ear. Users of the earplugs were not aware of the ineffectiveness of the product and relied on the 3M Combat earplugs to protect their hearing. Veterans and active military personnel may have sustained hearing loss or damage as a result of the defective earplugs.

Hernia Mesh

A hernia occurs when an organ, intestine, or fatty tissue squeezes through a weak area or hole in the muscle. Hernia mesh is used by surgeons to repair the hernia. The mesh can also be used for the treatment of surgical wounds. Several types of hernia mesh have been linked to serious complications for patients, including allergic reactions, mesh erosion or failure, abdominal pain, organ perforation, bowel obstruction, and intestinal fistulas. Some manufacturers of hernia mesh failed to warn patients of the risks associated with the use of the product. If you’ve been injured due to the use of hernia mesh, you may have a product liability claim.

Juul E-Cigarettes

Juul is the top-selling brand of e-cigarettes in the United States. Now the Centers for Disease Control is warning that using Juul e-cigarettes can be dangerous to consumers, especially young people. Because of the high level of nicotine salts contained in Juul e-cigarettes, the product is extremely dangerous for the brains of teenagers and young adults.

While Juul was intended to be used by smokers who were trying to quit nicotine, manufacturers began marketing the product to teenagers who were not even smokers. It led consumers to believe that Juul was a safe alternative to smoking. Much of this marketing was directed toward young adults. The marketing campaigns, coupled with the availability of different flavors of e-cigarettes, led to many teens and young people using the product even though they had never smoked before. These individuals are now fighting addiction and the long-term health effects of Juul e-cigarettes.


Opioid addiction has had a devastating effect on millions of families across the country. The manufacturers and distributors of opioids such as OxyContin and Percocet have repeatedly downplayed the addictive nature of their product, and opioids should never have been prescribed on a long-term basis. Opioid addiction can cause serious health problems and can lead to complicated and expensive rehabilitation, lost wages and mental health issues. Individuals who have been injured by opioid addiction deserve compensation for what they lost.


Monsanto’s Roundup is one of the most widely-used weed killers in the world. Recent studies now show that Roundup may cause cancer in people who use Roundup either on a regular basis or occasionally around the home. Monsanto has known for years about the link between Roundup and non-Hodgkin’s lymphoma but has continued to market its product as safe for consumers. Three verdicts have now awarded victims substantial damages, finding that Roundup was a contributing factor to cancer.


Xeljanz is a popular drug used to treat rheumatoid arthritis, ulcerative colitis, and psoriatic arthritis. In 2019, the FDA approved a black box warning for the product warning consumers of the risk of blood clots and potential death for users of the drug. Studies show that Xeljanz, at higher dosages, places users at an increased risk of developing dangerous blood clots. There is evidence that manufacturer Pfizer was aware of the safety issues at higher dosages and yet continued to market the product as safe.